ArticleCureus2025

A Retrospective Study of Rabbit Anti-T Lymphocyte Globulin (rATLG) as a Second-Line Therapy in Transplant-Ineligible Severe Aplastic Anemia Patients.

Aritra Saha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.